Dermatology News

The NIH has awarded Emma Guttman-Yassky, MD, PhD, a $6.6 million grant to investigate dupilumab as a treatment for children with alopecia areata, Mount Sinai announced in a press release.

Initiating infantile hemangioma treatment with propranolol 2 mg/kg per day did not yield more adverse events than 1 mg/kg per day, according to a study.

Ruxolitinib cream 1.5% was safe and well tolerated up for the short- and long-term treatment of atopic dermatitis in adolescents, according to an analysis of two phase 3 studies.

Acrochordons, also known as skin tags or fibroepithelial polyps, are correlated with metabolic disease and obesity in pediatric patients, according to a study.

Participation in the Pediatric Academic Societies Meeting is back to pre-COVID-19 levels of engagement, according to one of the event’s program chairs.

Stigma has a major impact on mental health and quality of life for pediatric patients with chronic skin diseases, according to a study.

The FDA has accepted Dermavant Science’s supplemental new drug application for Vtama cream 1% for the treatment of atopic dermatitis in adults and children aged 2 years and older, the company announced in a press release.

Port-wine birthmarks in infants were nearly all cleared with weekly pulsed dye laser treatments, according to a study.

Ritlecitinib was well tolerated and safe when continually used to treat alopecia areata in patients aged 12 years and older, according to a study.

Over the years, an old friend, Michael Cater, MD, a pediatrician at Children's Hospital of Orange County, California, has shared numerous interesting cases, some from exotic places during his time in the Army.